Fisetin is a naturally occurring
flavonoid that has been reported to inhibit the proliferation and to induce apoptotic cell death in several
tumor cells. However, the apoptosis-inducing effect of
fisetin on tumor cell lines was investigated besides HeLa cells. In this study, we found that
fisetin induced apoptosis of HeLa cells in a dose- and time-dependent manner, as evidenced by nuclear staining of 4'-6-Diamidino-2-phenylindole (
DAPI), flow cytometry assay, and
Annexin-V/PI double-labeling. In addition,
fisetin triggered the activations of caspases-3 and -8 and the cleavages of
poly (ADP-ribose) polymerase, resulting in apoptosis induction. Moreover, treatment of HeLa cells with
fisetin induced a sustained activation of the phosphorylation of ERK1/2, and inhibition of ERK1/2 by
PD98059 (MEK1/2 inhibitor) or transfection with the mutant ERK1/2 expression vector significantly abolished the
fisetin-induced apoptosis through the activation of
caspase-8/-3 pathway. The in vivo xenograft mice experiments revealed that
fisetin significantly reduced
tumor growth in mice with HeLa
tumor xenografts. In conclusion, our results indicated that
fisetin exhibited anti-
cancer effect and induced apoptosis in HeLa cell lines both in vitro and in vivo.